Literature DB >> 9760126

Lazaroid-enhanced survival of grafted dopamine neurons does not increase target innervation.

L Björklund1, N Vidal, I Strömberg.   

Abstract

The lazaroid U-74006F enhances survival of grafted ventral mesencephalic neurons. In this study the intraocular grafting model was used and survival and outgrowth from fetal ventral mesencephalic grafts treated with U-74006F was evaluated in nigrostriatal co-grafts. Fetal lateral ganglionic eminence was implanted into the anterior eye chamber and left to mature. Fetal ventral mesencephalon was then implanted and the eyes were treated with U-74006F. The lazaroid treatment enhanced survival of tyrosine hydroxylase (TH)-positive neurons, but did not enhance TH-positive nerve fiber growth into the striatal portions of the co-grafts. However, a marked increase in nerve fiber formation was found within the ventral mesencephalic grafts. In conclusion, increased cell survival enhanced nerve fiber formation within the ventral mesencephalic portion of the co-graft and not, as expected, in the striatal part.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9760126     DOI: 10.1097/00001756-199808240-00024

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures.

Authors:  Sara af Bjerkén; Heather A Boger; Matthew Nelson; Barry J Hoffer; Ann-Charlotte Granholm; Ingrid Strömberg
Journal:  Brain Res       Date:  2006-12-19       Impact factor: 3.252

3.  PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice.

Authors:  YaJun Zhang; Ann-Charlotte Granholm; Kyounghee Huh; Lufei Shan; Oscar Diaz-Ruiz; Nasir Malik; Lars Olson; Barry J Hoffer; Carl R Lupica; Alexander F Hoffman; Cristina M Bäckman
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.